Compare Coursera Inc (COUR) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Coursera Inc vs GeneDx Holdings Corp — how do they compare? Coursera Inc trades at $5.2 (market cap $1.39B), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: GeneDx Holdings Corp is the larger of the two by market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Coursera Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Coursera Inc for 47 Days and GeneDx Holdings Corp for 19 Days on average.
| COUR | WGS | |
|---|---|---|
Market Cap | $1.39B | $2.02B |
Volume | 9,728,980 | 734,640 |
Sector | Consumer Staples | Health |
52-Week High | $10.73 | $167.51 |
52-Week Low | $4.64 | $34.51 |
Typical Hold Time | 47 Days | 19 Days |
Enterprise Value | $648.49M | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Coursera (COUR) trades at $5.16, up 0.98% with a mixed technical picture showing bullish overall signals but bearish moving averages. The company shows improving revenue growth from $524M in 2022 to $758M in 2025, though it remains unprofitable with a -15.39% net margin. Recent news highlights strong institutional interest with Deutsche Bank acquiring 1.7M shares and positive analyst sentiment with 52.94% buy ratings.
The stock presents a growth opportunity with 44% subscriber growth and $85M synergy targets, but faces execution risks from ongoing losses and competitive pressures. With a consensus price target of $7.40 representing 43% upside, the bullish analyst outlook contrasts with fundamental profitability challenges that require careful monitoring.
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Coursera Inc
Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
